跳至主要内容
临床试验/NCT01039220
NCT01039220已完成不适用

Incidence of H1N1v Influenza-like Illness and Risk Factors for Serious Influenza Forms in HIV Infected Patients

French National Agency for Research on AIDS and Viral Hepatitis2 个研究点 分布在 1 个国家目标入组 1,266 人开始时间: 2009年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,266
试验地点
2
主要终点
Serious forms (see definition above) identified by any clinical site or hospitalisation unit-Controls: Patients of the randomly selected sample (see survey sampling).

研究概览

简要总结

To estimate the incidence of H1N1v influenza-like illness and to study the risk factors for serious influenza forms during pandemic period in French HIV infected patients.

  • Definitions:

  • Influenza like illness is defined as fever> 37°8C and cough or pharyngalgia. (Centers for Disease Control definition).

  • Serious forms of influenza-like illness is defined by hospitalization within 14 days onset of symptoms or death attributed to influenza like illness.

  • Design:

  • Survey sampling for estimating H1N1v influenza-like illness incidence.

  • Out of approximately 50 000 patients under follow-up in one of the 40 ANRS centres, a sub-group will be selected by random sampling. Sampling will be stratified by centre and sampling fraction per site will vary in order to select 60 to 80 patients for this study per site. A total of 2500 to 3000 patients will be selected to allow for estimating the incidence of H1N1v influenza-like illness with an adequate precision.

Selected patients will be asked to contact the clinical staff on site as soon as any influenza like symptoms appear. In the case of influenza like illness patients are requested to attend to the clinic within 24 hours for physical examination and naso-pharyngeal swab for diagnosis of A(H1N1)v infection.

Nested case-control study for the determination of risk factors for serious forms:

  • Cases: Serious forms (see definition above) identified by any clinical site or hospitalisation unit.
  • Controls: Patients of the randomly selected sample (see survey sampling above), presenting with influenza-like illness without any criterion for severity.

Exhaustivity check:

The exhaustivity of symptomatic forms will be assessed a posteriori by merging information from all available data sources.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Able to give written consent
  • Covered by French Social Security
  • HIV-infected (infection attested by the patient's chart)
  • pregnant women
  • Control and sample to estimate incidence
  • Patients followed for their HIV-infection in an ANRS center
  • Serious form
  • Hospitalization whatever is the service in 14 days consecutive to a H1N1v influenza syndrome such as defined, or death consecutive to a H1N1v influenza syndrome such as defined.

排除标准

  • patients for whom a H1N1v influenza syndrome can be informed at the beginning of the study.
  • Under protection(saving) of justice

结局指标

主要结局

Serious forms (see definition above) identified by any clinical site or hospitalisation unit-Controls: Patients of the randomly selected sample (see survey sampling).

次要结局

  • Exhaustivity check: The exhaustivity of symptomatic forms will be assessed a posteriori by merging information from all available data sources.

研究者

发起方
French National Agency for Research on AIDS and Viral Hepatitis
申办方类型
Other Gov

研究点 (2)

Loading locations...

相似试验